Cronos Group Inc (CRON) Stock Price Today—Real Time Charts and Quotes

Q: What are the 52-week high and low prices for Cronos Group Inc (CRON)?

CRON has a 52-week high of $2.66 and a 52-week low of $2.55, with the current price at $2.58.

Q: What is the price-to-earnings (P/E) ratio of Cronos Group Inc (CRON)? What does it indicate?

The current P/E ratio (TTM) of CRON is -107.2674224822695, indicating how much investors pay for each dollar of earnings. A higher P/E ratio often reflects stronger growth expectations, while a lower P/E ratio may suggest a more attractive valuation or slower growth. Comparing it with the average P/E of the Drug Manufacturers - Specialty & Generic industry for a better context.

Q: What is the market cap of Cronos Group Inc (CRON)?

Cronos Group Inc (CRON) currently has a market cap of approximately $1B.

Q: What is the most recent quarterly earnings per share (EPS) for Cronos Group Inc (CRON)?

Cronos Group Inc (CRON)'s diluted earnings per share (Diluted EPS) is -0.0245785425751845. EPS = Net Income / Total Diluted Shares, which is a key metric for measuring a company's profitability.

Q: Should you buy or sell Cronos Group Inc (CRON) now?

As of now, CRON is trading at $2.58, with a P/E ratio of -107.2674224822695 and a diluted EPS of -0.0245785425751845. Your buy or sell decisions should be based on your investment goals and risk tolerance. We recommend making an overall judgment by considering Cronos Group Inc's financial reports, the outlook of the Drug Manufacturers - Specialty & Generic sector, and your own holdings. Investing involves risk—please make decisions prudently.

Q: What factors can affect the stock price of Cronos Group Inc (CRON)?

Key factors include: company quarterly reports (revenue, EPS), competition and trends in the Drug Manufacturers - Specialty & Generic sector, macroeconomic environment (interest rate, inflation), market sentiment, as well as major events like product releases and mergers & acquisitions.

Q: How to buy Cronos Group Inc (CRON) stock?

You can buy Cronos Group Inc (CRON) through Gate. Sign up for a Gate account and complete identity verification, then go to the Cronos Group Inc trading page to make a purchase. Gate supports fractional share trading, so you can start investing without buying a whole share.

$2.58

-$0.07(-2.64%)

*Data last updated: 2026-04-29 19:26 (UTC+8)

As of 2026-04-29 19:26, Cronos Group Inc (CRON) is priced at $2.58, with a total market cap of $1.00B, a P/E ratio of -107.26, and a dividend yield of 0.00%. Today, the stock price fluctuated between $2.55 and $2.66. The current price is 1.17% above the day's low and 3.00% below the day's high, with a trading volume of 769.38K. Over the past 52 weeks, CRON has traded between $2.55 to $2.66, and the current price is -3.00% away from the 52-week high.

CRON Key Stats

Yesterday's Close$2.70

Market Cap$1.00B

Volume769.38K

P/E Ratio-107.26

Dividend Yield (TTM)0.00%

Diluted EPS (TTM)0.03

Net Income (FY)-$9.44M

Revenue (FY)$193.36M

Earnings Date2026-05-11

EPS Estimate0.01

Revenue Estimate$42.20M

Shares Outstanding372.03M

Beta (1Y)1.205

About CRON

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

CEOMichael Ryan Gorenstein

HeadquartersStayner,ON,CA

Official Websitehttps://www.thecronosgroup.com

Employees (FY)610.00

Average Revenue (1Y)$316.98K

Net Income per Employee-$15.48K

Learn More about Cronos Group Inc (CRON)

Gate Learn Articles

OpenClaw vs. Hermes Agent: A 2026 Guide to Choosing Self-Hosted AI Assistant Frameworks

For self-custody scenarios, this provides an objective comparison of the architecture, channels, tools and memory design, security operations, and target user groups of OpenClaw (TypeScript) and Hermes Agent (Python). It is designed to help you select an auditable and deployable AI assistant technology as functionalities converge, with a focus on least privilege and trial verification.

2026-04-28

Tilray Price Forecast: Q2 Revenue Hits $217.5 Million as International Operations Expand

Tilray (TLRY) posted second-quarter revenue of $217.5 million for fiscal year 2026, setting a new quarterly record fueled by the expansion of its international cannabis operations and distribution strategy. This article examines challenges in its beverage and wellness segments, evaluates its international market strategy, and reviews industry movements at Cronos and Canopy. Drawing on market forecasts, it offers investors a comprehensive perspective on Tilray’s stock price outlook.

2026-01-16

What is DOGEAI Using AI to Expose Waste and Inefficiency in Government Spending

DOGEAI is a project full of potential, which utilizes AI technology to reveal waste and inefficiencies in government spending, while promoting transparency and accessibility of government data through an open-source model and community participation. Although the project is still in its early stages, it has already demonstrated significant value and impact. In the future, with continuous technological advancements and community contributions, DOGEAI is expected to become a major force in the field of government data transparency.

2025-02-06

Cronos Group Inc (CRON) FAQ

What's the stock price of Cronos Group Inc (CRON) today?

Cronos Group Inc (CRON) is currently trading at $2.58, with a 24h change of -2.64%. The 52-week trading range is $2.55–$2.66.

What are the 52-week high and low prices for Cronos Group Inc (CRON)?

What is the price-to-earnings (P/E) ratio of Cronos Group Inc (CRON)? What does it indicate?

What is the market cap of Cronos Group Inc (CRON)?

What is the most recent quarterly earnings per share (EPS) for Cronos Group Inc (CRON)?

Should you buy or sell Cronos Group Inc (CRON) now?

What factors can affect the stock price of Cronos Group Inc (CRON)?

How to buy Cronos Group Inc (CRON) stock?

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.